The goal of the Tumor Imaging working group is to develop standardized consensus recommendations for imaging response evaluation in clinical trials for benign NF tumors. This includes guidelines for image acquisition, target lesion selection, image interpretation by volumetric analysis, and trial design.
Current group leaders: Eva Dombi, MD, and Brigitte Widemann, MD
1. Dombi E, Ardern-Holmes SL, Babovic-Vuksanovic D, et al. Recommendations for imaging tumor response in neurofibromatosis clinical trials. Neurology 2013 Nov 19;81(21 Suppl 1):S33-S40. [PDF]